Most sold healthcare stocks in Q2 2022
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2022, measured as net reductions in reported share positions from Q1 2022 into Q2 2022. Notable reductions at the top of this list include SANOFI-ADR (SNY), BRISTOL-MYERS SQUIBB CO (BMY), PFIZER INC (PFE), ABBOTT LABORATORIES (ABT). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| SNY | SANOFI-ADR | -15,096,052 | -$876.70M | 0 | 2 | 3 | 0 | 6 |
| BMY | BRISTOL-MYERS SQUIBB CO | -10,468,806 | -$654.26M | 0 | 7 | 11 | 2 | 20 |
| PFE | PFIZER INC | -8,743,412 | -$437.18M | 1 | 5 | 11 | 1 | 20 |
| ABT | ABBOTT LABORATORIES | -5,984,666 | -$924.37M | 0 | 5 | 7 | 0 | 16 |
| AVTR | AVANTOR INC | -5,540,472 | -$225.37M | 1 | 3 | 2 | 1 | 7 |
| NVS | NOVARTIS AG-SPONSORED ADR | -4,972,607 | -$526.62M | 0 | 3 | 4 | 1 | 8 |
| PRGO | Perrigo Company PLC | -3,324,059 | -$120.48M | 0 | 1 | 2 | 1 | 3 |
| PRCT | PROCEPT BIOROBOTICS CORP | -3,202,667 | -$115.70M | 0 | 0 | 2 | 0 | 2 |
| THC | TENET HEALTHCARE CORP | -2,183,703 | -$189.44M | 0 | 2 | 0 | 1 | 2 |
| UNH | UNITEDHEALTH GROUP INC | -1,987,280 | -$951.70M | 0 | 7 | 19 | 2 | 28 |
| WRBY | WARBY PARKER INC-CLASS A | -1,907,699 | -$412.70M | 0 | 0 | 2 | 1 | 3 |
| EDIT | EDITAS MEDICINE INC | -1,447,315 | -$29.46M | 0 | 0 | 1 | 1 | 1 |
| GH | GUARDANT HEALTH INC | -1,334,513 | -$204.44M | 0 | 0 | 2 | 0 | 2 |
| MRNA | MODERNA INC | -1,325,543 | -$334.68M | 1 | 4 | 1 | 0 | 8 |
| BAX | BAXTER INTERNATIONAL INC | -1,311,875 | -$119.57M | 0 | 5 | 3 | 1 | 10 |
| CTLT | CATALENT INC | -1,278,584 | -$149.68M | 0 | 2 | 3 | 1 | 5 |
| OSCR | OSCAR HEALTH INC - CLASS A | -1,269,385 | -$97.00M | 0 | 2 | 0 | 1 | 5 |
| GILD | GILEAD SCIENCES INC | -1,268,372 | $81.03M | 1 | 8 | 3 | 0 | 12 |
| BHC | BAUSCH HEALTH COS INC | -1,244,223 | -$794.69M | 1 | 0 | 4 | 0 | 6 |
| IONS | IONIS PHARMACEUTICALS INC | -1,189,073 | -$46.56M | 0 | 1 | 4 | 0 | 6 |
| CSTL | CASTLE BIOSCIENCES INC | -1,177,711 | -$53.23M | 0 | 0 | 1 | 1 | 1 |
| ARDX | ARDELYX INC | -1,086,600 | -$1.26M | 0 | 0 | 1 | 0 | 1 |
| CI | THE CIGNA GROUP | -1,084,823 | $154.68M | 0 | 3 | 4 | 2 | 8 |
| AUPH | AURINIA PHARMACEUTICALS INC | -1,077,805 | -$16.11M | 0 | 1 | 2 | 0 | 3 |
| PMVP | PMV PHARMACEUTICALS INC | -1,076,000 | -$22.40M | 0 | 0 | 0 | 1 | 0 |
| IQV | IQVIA HOLDINGS INC | -1,050,247 | -$277.07M | 0 | 2 | 2 | 1 | 5 |
| XRAY | DENTSPLY SIRONA INC | -992,848 | -$182.95M | 0 | 3 | 0 | 1 | 3 |
| EVH | EVOLENT HEALTH INC - A | -991,574 | -$41.81M | 0 | 0 | 1 | 0 | 1 |
| IVVD | INVIVYD INC | -985,114 | -$4.50M | 0 | 1 | 0 | 1 | 1 |
| ALLO | ALLOGENE THERAPEUTICS INC | -972,200 | -$8.84M | 0 | 1 | 0 | 1 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -863,775 | -$89.25M | 0 | 1 | 2 | 1 | 5 |
| OPCH | OPTION CARE HEALTH INC | -846,412 | -$24.21M | 0 | 1 | 0 | 1 | 1 |
| A | AGILENT TECHNOLOGIES INC | -836,082 | -$203.36M | 0 | 0 | 6 | 0 | 7 |
| ZTS | ZOETIS INC | -764,158 | -$331.51M | 0 | 5 | 6 | 0 | 14 |
| ACAD | ACADIA PHARMACEUTICALS INC | -707,325 | -$17.89M | 0 | 0 | 0 | 2 | 1 |
| ELV | ELEVANCE HEALTH INC | -589,329 | -$358.55M | 1 | 5 | 7 | 0 | 15 |
| CVM | CEL-SCI CORP | -554,000 | -$2.05M | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -501,800 | -$85.74M | 1 | 8 | 11 | 0 | 27 |
| AVIR | ATEA PHARMACEUTICALS INC | -501,000 | -$3.70M | 0 | 1 | 1 | 0 | 2 |
| PGEN | PRECIGEN INC | -487,448 | -$6.49M | 0 | 1 | 1 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -449,703 | -$1.11M | 0 | 0 | 1 | 0 | 1 |
| EHC | ENCOMPASS HEALTH CORP | -447,852 | -$79.44M | 0 | 1 | 3 | 0 | 4 |
| WEAV | WEAVE COMMUNICATIONS INC | -443,176 | -$23.18M | 0 | 0 | 1 | 1 | 1 |
| OGN | ORGANON & CO | -439,725 | -$20.17M | 0 | 2 | 3 | 2 | 8 |
| GERN | GERON CORP | -439,100 | -$557.50K | 0 | 0 | 2 | 0 | 2 |
| CMRX | CHIMERIX INC | -429,840 | -$4.56M | 0 | 0 | 1 | 1 | 1 |
| INVA | INNOVIVA INC | -417,160 | -$30.10M | 0 | 0 | 1 | 1 | 1 |
| HCSG | HEALTHCARE SERVICES GROUP | -382,600 | -$7.42M | 0 | 0 | 1 | 0 | 1 |
| MRSN | MERSANA THERAPEUTICS INC | -348,881 | -$1.03M | 0 | 0 | 1 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | -320,484 | -$15.64M | 0 | 0 | 3 | 0 | 4 |
Frequently asked questions about Most sold healthcare stocks in Q2 2022
What are the most sold Healthcare stocks in Q2 2022?
The most sold healthcare stocks in Q2 2022 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2022?
Among filers in this sector, net reductions were largest in companies such as SANOFI-ADR (SNY), BRISTOL-MYERS SQUIBB CO (BMY), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.